Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

Exclusion Criteria

• •Active guttate, erythrodermic, or pustular psoriasis at the time of the screening visit
• •Pregnant or breast-feeding females
• •Evidence of skin conditions at the time of the screening visit (e.g., eczema) that would interfere with evaluations of the effect of the investigational product on psoriasis